Skandinaviska Enskilda Banken (SEB)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3M | Buy |
|
|||||
|
2025
Q1 | $26.5M | Buy |
|
|||||
|
2024
Q4 | $32M | Buy |
|
|||||
|
2024
Q3 | $22.7M | Sell |
|
|||||
|
2024
Q2 | $20.7M | Hold |
|
|||||
|
2024
Q1 | $18M | Buy |
|
|||||
|
2023
Q4 | $2.34M | Buy |
|
|||||
|
2023
Q3 | $2.08M | Hold |
|
|||||
|
2023
Q2 | $1.53M | Buy |
|
|||||
|
2023
Q1 | $1.33M | Hold |
|
|||||
|
2022
Q4 | $1.37M | Buy |
|
|||||
|
2022
Q3 | $1.13M | Sell |
|
|||||
|
2022
Q2 | $1.37M | Sell |
|
|||||
|
2022
Q1 | $2.11M | Sell |
|
|||||
|
2021
Q4 | $1.91M | Sell |
|
|||||
|
2021
Q3 | $2.59M | Buy |
|
|||||
|
2021
Q2 | $2.22M | Sell |
|
|||||
|
2021
Q1 | $2.65M | Buy |
|
|||||
|
2020
Q4 | $2.15M | Sell |
|
|||||
|
2020
Q3 | $2.28M | Buy |
|
|||||
|
2020
Q2 | $3.1M | Buy |
|
|||||
|
2020
Q1 | $2.13M | Buy |
|
|||||
|
2019
Q4 | $2.28M | Buy |
|
|||||
|
2019
Q3 | $1.51M | Sell |
|
|||||
|
2019
Q2 | $2.17M | Buy |
|
|||||
|
2019
Q1 | $3.4M | Sell |
|
|||||
|
2018
Q4 | $3.47M | Buy |
|
|||||
|
2018
Q3 | $4.83M | Buy |
|
|||||
|
2018
Q2 | $5.22M | Buy |
|
|||||
|
2018
Q1 | $3.21M | Buy |
|
|||||
|
2017
Q4 | $3.42M | Buy |
|
|||||
|
2017
Q3 | $2.75M | Buy |
|
|||||
|
2017
Q2 | $3M | Buy |
|
|||||
|
2017
Q1 | $2.59M | Sell |
|
|||||
|
2016
Q4 | $2.93M | Sell |
|
|||||
|
2016
Q3 | $30.5M | Sell |
|
|||||
|
2016
Q2 | $35.3M | Sell |
|
|||||
|
2016
Q1 | $49.2M | Sell |
|
|||||
|
2015
Q4 | $64.5M | Buy |
|